Overview
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Description
The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.
Eligibility
Inclusion Criteria:
- Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
- Oral and written informed consent
Exclusion Criteria:
- Any individual who does not give oral and written consent for participation